| Dr Robert Elmer Westlake Jr, MD | |
|
5700 W Genesee St, Suite 201n, Camillus, NY 13031-3200 | |
| (315) 488-1438 | |
| (315) 468-0792 |
| Full Name | Dr Robert Elmer Westlake Jr |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 5700 W Genesee St, Camillus, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215964051 | NPI | - | NPPES |
| 00562583 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 137940 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Elmer Westlake Jr, MD 1001 W Fayette Street, Ste 400, Syracuse, NY 13204 Ph: (315) 472-1488 | Dr Robert Elmer Westlake Jr, MD 5700 W Genesee St, Suite 201n, Camillus, NY 13031-3200 Ph: (315) 488-1438 |
News Archive
Researchers from the Hotchkiss Brain Institute (HBI) and the Snyder Institute for Chronic Diseases at the University of Calgary's Faculty of Medicine have discovered a pathway that may contribute to the symptoms related to Crohn's disease and ulcerative colitis, collectively known as Inflammatory Bowel Disease.
A new study out of Harvard University reveals that the protective stratospheric ozone layer above the central United States is vulnerable to erosion during the summer months from ozone-depleting chemical reactions, exposing people, livestock and crops to the harmful effects of UV radiation.
St. Jude Medical, Inc., a global medical device company, today announced that an analysis of the benefits to using a Fractional Flow Reserve-guided intervention strategy found that the technology can improve patient outcomes while saving millions of Euros.
Juventas Therapeutics, a privately-held, clinical-stage company developing novel regenerative therapies for treatment of cardiovascular disease, is pleased to report that it is actively enrolling patients in a placebo-controlled, randomized double-blinded Phase IIa study evaluating the safety and efficacy for JVS-100 in patients with Rutherford Class 4 or 5 critical limb ischemia.
› Verified 8 days ago
Dr. Okosun Edoro, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 5700 W Genesee St Ste 109, Camillus, NY 13031 Phone: 315-487-1573 Fax: 315-487-2418 | |
Margaret Spinosa, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 260 Township Blvd Ste 20, Camillus, NY 13031 Phone: 315-708-0190 Fax: 315-488-3284 | |
Theodore Koh, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 260 Township Blvd, Ste 20, Camillus, NY 13031 Phone: 315-708-0091 Fax: 315-708-0194 | |
Scott A Edison, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 260 Township Blvd, Ste 20, Camillus, NY 13031 Phone: 315-708-0091 Fax: 315-708-0194 | |
Martin T Noonan, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5417 W Genesee St Ste 3, Camillus, NY 13031 Phone: 315-476-2325 | |
Dr. John Sun, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 260 Township Blvd, Ste 20, Camillus, NY 13031 Phone: 315-708-0091 Fax: 315-708-0194 |